Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | SPECIALITY HEALTHCARE SOLUTIONS | Awarded | 1 | ₹16,368 |
| 2 | Schedule 2 | FLORENCE INDIA | Awarded | 1 | ₹9,784.50 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
5 Jan 2024, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
BOQBID
5799257
GEM/2023/B/4394926
Two Packet Bid
Imatinib Mesylate 400 mg Cap,Imatinib Mesylate 100 mg Cap,Dont Quote S No 3,Dont Quote S No 4,Dont
30 days
West Bengal; Kolkata
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹3
20%
Exempted
5 Jan 2024
26 Dec 2023
5 Jan 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Imatinib Mesylate 400 mg Cap | 7,440 | No | Kolkata | 30 |
| 2 | Imatinib Mesylate 100 mg Cap | 1,650 | No | Kolkata | 30 |
| 3 | Dont Quote S No 3 | 1 | No | Kolkata | 30 |
| 4 | Dont Quote S No 4 | 1 | No | Kolkata | 30 |
| 5 | Dont Quote S No 5 | 1 | No | Kolkata | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5799257.pdf
GEM_BID
rfp_opt_-1_2023-12-26-13-38-11_1851c0da68e1f18327878297b2bde151.pdf
BOQ
boq_item_re_e23_ifa_598_2023-12-26-13-38-11_a59f8d94dfb1f31a67fd65f8c0a4a73c.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .